Literature DB >> 2987410

High- and low-affinity binding components for [3H]imipramine in rat cerebral cortex.

P G Conway, D J Brunswick.   

Abstract

The present study demonstrates that [3H]imipramine binds to both high- and low-affinity imipramine binding components on membranes prepared from rat cerebral cortex. Scatchard and computer analyses of saturation experiments using a wide range of [3H]imipramine concentrations (0.5 nM-50 nM) revealed the presence of two binding components. Inhibition experiments in which membranes were incubated with [3H]imipramine and various concentrations of unlabelled imipramine gave shallow inhibition curves with a Hill coefficient of 0.60 +/- 0.04. When dissociation rates of imipramine were studied, biphasic dissociation curves were obtained with apparent half-times of dissociation of 2.5 +/- 0.4 min and 18.5 +/- 2.5 min. Thus analysis of saturation, competition, and dissociation experiments indicate that [3H]imipramine binds to low as well as high-affinity binding sites in rat cortex.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2987410     DOI: 10.1111/j.1471-4159.1985.tb05494.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  3 in total

1.  Drug inhibition indicates a single-site model of the 5-HT uptake site/antidepressant binding site in rat and human brain.

Authors:  J O Marcusson; A Andersson; I Bäckström
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

2.  Low brain serotonin transporter binding in major depressive disorder.

Authors:  Andrew B Newberg; Jay D Amsterdam; Nancy Wintering; Justine Shults
Journal:  Psychiatry Res       Date:  2012-06-12       Impact factor: 3.222

3.  Differences in serotonin transporter binding affinity in patients with major depressive disorder and night eating syndrome.

Authors:  J D Lundgren; J Amsterdam; A Newberg; K C Allison; N Wintering; A J Stunkard
Journal:  Eat Weight Disord       Date:  2009-03       Impact factor: 4.652

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.